Skip to main content

Volume 15 Supplement 1

B cells in autoimmune diseases: Part 2


The supplement was proposed by the journal and content was developed in consultation with the Editors-in-Chief. Articles have been independently prepared by the authors and have undergone the journal's standard peer review process. Publication of the supplement was supported by Medimmune.

This supplement is being published in two parts. Part 1 can be found at Further articles will be added to this supplement later in the year.

  1. B cell abnormalities contribute to the development and progress of autoimmune disease.Traditionally, the role of B cells in autoimmune disease was thought to be predominantly limited tothe production of autoan...

    Authors: Ioannis Kalampokis, Ayumi Yoshizaki and Thomas F Tedder
    Citation: Arthritis Research & Therapy 2013 15(Suppl 1):S1
  2. B cells are believed to be central to the disease process in systemic lupuserythematosus (SLE), making them a target for new therapeutic intervention. In recentyears there have been many publications regarding...

    Authors: Venkat Reddy, David Jayne, David Close and David Isenberg
    Citation: Arthritis Research & Therapy 2013 15(Suppl 1):S2
  3. B lymphocytes are the source of humoral immunity and are thus a critical component of the adaptive immune system. However, B cells can also be pathogenic and the origin of disease. Deregulated B-cell function ...

    Authors: Stephan Bl├╝ml, Kathleen McKeever, Rachel Ettinger, Josef Smolen and Ronald Herbst
    Citation: Arthritis Research & Therapy 2013 15(Suppl 1):S4

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2022 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    149 days submission to accept (Median)

    2022 Usage 
    17,226 Altmetric mentions